Merck KGaA to develop immunotherapies with F-star
German Merck has option to licence LAG3-PDL1 drug.
X
Merck KGaA to develop immunotherapies with F-star
https://pharmaphorum.com/news/merck-kgaa-develop-cancer-immunotherapies-f-star/
F-star
F-star and Denali sign potential $1bn antibody deal
Deal focuses on CNS bispecific antibodies.
Will the UK ever produce a world-class biotech company?
Kymab, F-star and Mission Therapeutics among crop of new UK biotechs.
